Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AIFC NASDAQ:ETHZ NASDAQ:FTLF NASDAQ:PLRZ On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAIFCALT5 Sigma$0.65-1.1%$0.93$0.63▼$10.80$90.90M1.713.13 million shs416,728 shsETHZFlag Ship Acquisition$5.31+4.3%$3.87$0.70▼$17.46$100.95M1.176.44 million shs183,352 shsFTLFFitLife Brands$10.47+0.9%$10.08$8.67▼$20.98$98.27M0.0224,797 shs7,971 shsPLRZPolyrizon$12.25-2.2%$13.72$2.88▼$18.20$22.91M-1.9166,719 shs1,141 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAIFCALT5 Sigma+3.33%-23.62%-32.98%-53.08%-93.57%ETHZFlag Ship Acquisition0.00%+14.90%+10.41%+73.72%+508,999,900.00%FTLFFitLife Brands+5.07%+4.64%+8.59%-28.97%-27.53%PLRZPolyrizon-3.62%-18.75%-23.38%-3.40%+159.54%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAIFCALT5 Sigma$0.65-1.1%$0.93$0.63▼$10.80$90.90M1.713.13 million shs416,728 shsETHZFlag Ship Acquisition$5.31+4.3%$3.87$0.70▼$17.46$100.95M1.176.44 million shs183,352 shsFTLFFitLife Brands$10.47+0.9%$10.08$8.67▼$20.98$98.27M0.0224,797 shs7,971 shsPLRZPolyrizon$12.25-2.2%$13.72$2.88▼$18.20$22.91M-1.9166,719 shs1,141 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAIFCALT5 Sigma+3.33%-23.62%-32.98%-53.08%-93.57%ETHZFlag Ship Acquisition0.00%+14.90%+10.41%+73.72%+508,999,900.00%FTLFFitLife Brands+5.07%+4.64%+8.59%-28.97%-27.53%PLRZPolyrizon-3.62%-18.75%-23.38%-3.40%+159.54%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAIFCALT5 Sigma 1.00SellN/AN/AETHZFlag Ship Acquisition 1.00SellN/AN/AFTLFFitLife Brands 2.25Hold$21.50105.45% UpsidePLRZPolyrizon 1.00SellN/AN/ACurrent Analyst Ratings BreakdownLatest PLRZ, AIFC, FTLF, and ETHZ Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/4/2026FTLFFitLife Brands Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C) ➝ Hold (C-)5/21/2026PLRZPolyrizon Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/4/2026PLRZPolyrizon Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)4/7/2026FTLFFitLife Brands Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell4/2/2026FTLFFitLife Brands Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$21.00 ➝ $18.00(Data available from 6/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAIFCALT5 Sigma$24.84M3.66N/AN/A$9.07 per share0.07ETHZFlag Ship Acquisition$4.11M24.56N/AN/A$29.12 per share0.18FTLFFitLife Brands$81.46M1.21$1.24 per share8.46$4.65 per share2.25PLRZPolyrizonN/AN/AN/AN/A$13.05 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAIFCALT5 Sigma-$344.51MN/AN/AN/AN/A-2,483.94%-68.25%-62.43%N/AETHZFlag Ship Acquisition-$6.17M-$159.65N/AN/AN/AN/A-185.71%-83.12%N/AFTLFFitLife Brands$6.33M$0.6017.339.10N/A6.64%18.31%8.21%N/APLRZPolyrizon-$3.34MN/AN/AN/AN/AN/AN/AN/AN/ALatest PLRZ, AIFC, FTLF, and ETHZ EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/18/2026Q1 2026AIFCALT5 SigmaN/A-$2.14N/A-$2.14N/A$4.71 million5/14/2026Q1 2026FTLFFitLife Brands$0.14$0.17+$0.03$0.17N/A$25.33 million4/11/2026Q4 2025AIFCALT5 SigmaN/A-$6.19N/A-$6.19N/A$5.37 million3/25/2026Q4 2025PLRZPolyrizonN/A$2.81N/A-$2.81N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAIFCALT5 SigmaN/AN/AN/AN/AN/AETHZFlag Ship AcquisitionN/AN/AN/AN/AN/AFTLFFitLife BrandsN/AN/AN/AN/AN/APLRZPolyrizonN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAIFCALT5 Sigma0.030.820.82ETHZFlag Ship Acquisition1.1110.0710.07FTLFFitLife Brands0.781.520.49PLRZPolyrizonN/A29.0329.03Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAIFCALT5 Sigma6.27%ETHZFlag Ship Acquisition4.07%FTLFFitLife Brands2.32%PLRZPolyrizonN/AInsider OwnershipCompanyInsider OwnershipAIFCALT5 Sigma0.21%ETHZFlag Ship Acquisition15.10%FTLFFitLife Brands61.40%PLRZPolyrizonN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAIFCALT5 Sigma170139.84 million139.54 millionN/AETHZFlag Ship Acquisition719.01 million16.14 millionN/AFTLFFitLife Brands209.39 million3.63 millionNot OptionablePLRZPolyrizonN/A1.87 millionN/AN/APLRZ, AIFC, FTLF, and ETHZ HeadlinesRecent News About These CompaniesPolyrizon Sets July 13, 2026 AGM to Vote on Board, Pay and Auditor MandatesJune 8 at 4:31 PM | tipranks.comPolyrizon Secures Three Key U.S. Sites for NASARIX Allergy TrialJune 8 at 4:31 PM | tipranks.comPolyrizon Ltd. Expands Clinical Trial Network for NASARIX™ Allergy Blocker with Two New U.S. SitesJune 8 at 9:50 AM | quiverquant.comQPolyrizon Makes Strong Clinical Progress: Secures Three U.S. Sites for NASARIX™ TrialJune 8 at 9:25 AM | globenewswire.comPolyrizon (NASDAQ:PLRZ) Upgraded to Hold at Wall Street ZenJune 7 at 1:08 AM | americanbankingnews.comPolyrizon Extends Exclusivity on Proposed 51% Acquisition of Arrow AviationJune 5, 2026 | tipranks.comPolyrizon (NASDAQ:PLRZ) Cut to "Sell" at Wall Street ZenMay 30, 2026 | americanbankingnews.comPolyrizon Appoints Veteran Entrepreneur Ami Oren to Board of DirectorsMay 27, 2026 | tipranks.comPolyrizon Stock Short Interest Report | NASDAQ:PLRZ | BenzingaMay 16, 2026 | benzinga.comPolyrizon Secures First U.S. Clinical Site for NASARIX Allergy Blocker TrialMay 13, 2026 | tipranks.comPolyrizon Ltd. Signs Clinical Trial Agreement for NASARIXTM Allergy Blocker Study in TexasMay 13, 2026 | quiverquant.comQPolyrizon Advances Towards Human Clinical Trials: Secures First U.S. Clinical Site for NASARIX™ Allergy Blocker Clinical TrialMay 13, 2026 | globenewswire.comPulse Equity: Emerging Outbreaks - Polyrizon's Approach to Broad and Rapidly Deployable ProtectionMay 11, 2026 | prnewswire.comPolyrizon Expands U.S. Patent Claims for Intranasal Drug Delivery PlatformMay 4, 2026 | tipranks.comPolyrizon Announces U.S. Patent Expansion for Its Intranasal Drug Delivery PlatformMay 4, 2026 | globenewswire.comPolyrizon Ltd. Files Divisional Patent Application for Advanced Trap & Target Intranasal Drug Delivery TechnologyApril 27, 2026 | quiverquant.comQPolyrizon Announces Filing of European Patent Application for Its Breakthrough Drug Delivery PlatformApril 27, 2026 | globenewswire.comPLRZ Share News TodayApril 19, 2026 | uk.investing.comPolyrizon Raises $3.5 Million via Registered Direct Offering and Private PlacementApril 14, 2026 | theglobeandmail.comPolyrizon Ltd. Ordinary Shares (PLRZ) Institutional HoldingsApril 8, 2026 | nasdaq.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePLRZ, AIFC, FTLF, and ETHZ Company DescriptionsALT5 Sigma NASDAQ:AIFC$0.65 -0.01 (-1.05%) As of 12:04 PM EasternALT5 Sigma Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments. The Biotechnology segment focuses on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. The Recycling segment is involved in a turnkey appliance recycling program. The company was founded by Edward R. Cameron in 1976 and is headquartered in Las Vegas, NV.Flag Ship Acquisition NASDAQ:ETHZ$5.31 +0.22 (+4.32%) As of 06/8/20261180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which is under preclinical trials that are man-made derivatives of CBD; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.FitLife Brands NASDAQ:FTLF$10.46 +0.10 (+0.92%) As of 12:18 PM Eastern This is a fair market value price provided by Massive. Learn more.FitLife Brands, Inc. provides nutritional supplements for health-conscious consumers in the United States and internationally. The company provides weight loss, sports nutrition, and general health products; sports nutrition products; weight loss and sports nutrition products; sports nutrition and general wellness formulations with an emphasis on natural, vegan, and organic ingredients; and male health and weight loss products, as well as other diet, health, and sports nutrition supplements and related products; and value-oriented sports nutrition and weight loss products. It offers MRC products which includes general health supplements; and natural skincare and beauty products. In addition, it markets its products under the brand names of NDS Nutrition, PMD Sports, SirenLabs, CoreActive, Nutrology, Metis Nutrition, iSatori, BioGenetic Laboratories, Energize, Dr. Tobias, All-Natural Advice, and Maritime Naturals through franchised stores, as well as through retail locations, which include specialty, mass, and online. The company was formerly known as Bond Laboratories, Inc. and changed its name to FitLife Brands, Inc. in September 2013. FitLife Brands, Inc. was incorporated in 2005 and is headquartered in Omaha, Nebraska.Polyrizon NASDAQ:PLRZ$12.25 -0.27 (-2.16%) As of 12:11 PM Eastern This is a fair market value price provided by Massive. Learn more.Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Apple's Siri AI Was Finally Announced, So Why Is the Stock Tanking? The Case for Intel Over Pure-Play Quantum Firms Has Temu-Owner PDD's Story Changed After Double Miss? Campbell's Soup Stock: Deep Value and a 7% Dividend Yield Walmart's No. 2 Ranking Hides a Digital Transformation Story AirJoule Technologies: A Cool Shot at a Multibagger Technology Stocks Just Got Cheaper—Here Are 5 Mega-Caps Worth a Closer Look Amprius Insiders Are Selling: Should Investors Be Worried? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
